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Abstract Several guanine nucleotide exchange factors (GEFs)
for Rho-GTPases have been identified, all of them containing a
Dbl homology (DH) and pleckstrin homology (PH) domain, but
exhibiting different specificities to the Rho family members, Rho,
Rac and Cdc42. We report here that KIAA0380, a protein with a
tandem DH/PH domain, an amino-terminal PDZ domain and a
regulator of G protein signalling (RGS) homology domain, is a
specific GEF for RhoA, but not for Rac1 and Cdc42, as
determined by GDP release, guanosine 5P-O-(3-thio)triphosphate
(GTPQS) binding and protein binding assays. When expressed in
J82 cells, DH/PH domain-containing forms of KIAA0380
induced actin stress fibers, whereas expression of the RGS
homology domain prevented lysophosphatidic acid (LPA)-
induced stress fiber formation.
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1. Introduction
Rho family GTPases, with the main members RhoA, Rac1/
2 and Cdc42, play essential roles in various cellular functions,
predominantly in organization of the actin cytoskeleton as
well as cell growth and transformation [1]. These GTPases
serve as molecular switches which are inactive in the GDP-
bound state and active in the GTP-bound state. Transition
from the GDP- to the GTP-bound state is catalyzed by spe-
ci¢c guanine nucleotide exchange factors (GEFs), some of
which were ¢rst identi¢ed as oncogene products [1,2].
Meanwhile, there is a large family of about 20 distinct pro-
teins exhibiting GEF activity towards Rho-GTPases. They all
contain in tandem a Dbl homology (DH) domain which is
responsible for the guanine nucleotide exchange activity and
a pleckstrin homology (PH) domain thought to be involved in
subcellular localization of the proteins [2,3]. Nevertheless,
some of these proteins exhibit GEF activity to only one spe-
ci¢c member of the Rho-GTPase family, e.g. RhoA, while
others can activate multiple Rho-GTPases with similar e⁄-
cacy [2]. Recently, a region with homology to regulators of
G protein signalling (RGS) has been identi¢ed in human
p115-RhoGEF and its murine homologue Lsc [4^6]. This
RGS homology domain appears to be a functional site for
interaction of these GEFs with heterotrimeric G proteins. In
fact, it has been shown that the GTPase activities of GK12 and
GK13 are enhanced by p115-RhoGEF and that on the other
hand, the guanine nucleotide exchange activity of p115-Rho-
GEF towards RhoA is enhanced by activated GK13 [4,5].
The aim of the present study was to characterize a putative
new member of the Rho-GEF family, namely KIAA0380, a
protein containing a DH domain in tandem with a PH do-
main as well as an RGS homology domain at the amino-
terminus [4,7]. We report here that KIAA0380 is a highly
speci¢c GEF for RhoA, but does not interact with Rac1
and Cdc42. Overexpression of KIAA0380 in human bladder
carcinoma (J82) cells resulted in actin stress ¢ber formation, a
cellular response known to be controlled by RhoA [1], where-
as expression of the amino-terminal RGS homology domain
prevented actin stress ¢ber formation induced by the G pro-
tein-coupled lysophosphatidic acid (LPA) receptor.
2. Materials and methods
2.1. Plasmids
cDNA encoding KIAA0380 (GenBank accession number
AB002378) was kindly provided by Dr T. Nagase (Kazusa DNA
Research Institute, Chiba, Japan). For the expression of di¡erent
myc-tagged variants of KIAA0380 in mammalian cells, i.e. the near
full-length protein containing the RGS, DH and PH domains
(KIAA0380-RGS/DH/PH, amino acids (aa) 111^1522), the carboxy-
terminal part with the DH and PH domains (KIAA0380-DH/PH, aa
637^1522) and the amino-terminus with the RGS homology domain
but lacking the DH and PH domains (KIAA0380-RGS, aa 92^637),
corresponding cDNA fragments were subcloned into the pCMV3 ex-
pression vector (Stratagene).
2.2. Puri¢cation of proteins
For puri¢cation of KIAA0380, a KIAA0380-DH/PH construct was
prepared by subcloning the corresponding cDNA fragment into the
baculovirus transfer vector pAcGHLT-A (PharMingen), allowing for
expression as a glutathione S-transferase (GST) fusion protein. Re-
combinant baculovirus was obtained by co-transfection of the con-
struct with BaculoGold DNA (PharMingen) using lipofectamine
(Gibco BRL). Sf9 cells infected with recombinant baculovirus were
lysed 72 h later by soni¢cation on ice in the presence of protease
inhibitors and supernatants were prepared. Thereafter, the GST fu-
sion protein was puri¢ed by glutathione Sepharose (Pharmacia) a⁄n-
ity chromatography. The GST fusion products of RhoA, Rac1 and
Cdc42 were expressed in Escherichia coli using the pGEX vector,
kindly provided by Dr A. Hall, University College London, and pu-
ri¢ed as described in [8]. The homogeneity of the recombinant pro-
teins was analyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE).
2.3. GDP/GTP exchange assays
Binding of GDP and the stable GTP analogue guanosine 5P-O-
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(3-thio)triphosphate (GTPQS) to Rho-GTPases was determined at
room temperature by the ¢lter binding method essentially as described
in [9]. In brief, for GDP binding, the recombinant GTPases were ¢rst
made nucleotide-free by incubation for 5 min in EDTA (2 mM)-con-
taining loading bu¡er, supplemented with 10 WM [3H]GDP (Amer-
sham). Thereafter, MgCl2 was added to a ¢nal concentration of 5 mM
and the incubation was continued for a further 20 min. Finally, pu-
ri¢ed recombinant KIAA0380-DH/PH equilibrated for 15 min in ex-
change bu¡er containing 1 mM GTP was added and the reaction
continued for the indicated periods of time. For binding of GTPQS,
unlabelled GDP (10 WM) was used in the loading bu¡er instead of
[3H]GDP and the exchange mixture contained 5 WM [35S]GTPQS (New
England Nuclear) instead of unlabelled GTP. Bound and free nucleo-
tides were separated by ¢ltration through nitrocellulose ¢lters.
2.4. Protein binding assay
Binding of KIAA0380 to Rho-GTPases was carried out essentially
as described in [3]. Brie£y, HEK-293 cells were transfected with myc-
tagged KIAA0380-RGS/DH/PH using the calcium phosphate method
and 48 h later, cells were lysed at 4‡C in a bu¡er containing 20 mM
Tris-HCl, pH 7.6, 100 mM NaCl, 2 mM EDTA, 0.5% Triton X-100,
0.2% sodium deoxycholate, 1 mM dithiothreitol, 1 mM phenylmethyl-
sulfonyl £uoride, 10 Wg/ml aprotinin and 10 Wg/ml leupeptin. Re-
combinant GST-fused GTPases (V50 Wg) immobilized on glutathione
Sepharose beads were ¢rst incubated with cell lysate from untrans-
fected cells (V700 Wg protein) for 1 h at 4‡C. Then, nucleotide-free,
GDP-bound or GTPQS-bound forms of the Rho-GTPases were pre-
pared exactly as described in [3]. Thereafter, the beads were incubated
for 16 h at 4‡C with lysates of transfected cells (600 Wg protein).
Finally, after three washes, the beads were resolved in Laemmli bu¡er,
subjected to SDS-PAGE and transferred to nitrocellulose for Western
blot analysis using an anti-myc antibody (9E10, Calbiochem). Immu-
noreactive proteins were visualized by enhanced chemoluminescence
(Amersham).
2.5. Phalloidin staining and £uorescence microscopy
Subcon£uent human bladder carcinoma (J82) cells [10] cultured as
in [11] and grown in 60 mm plastic dishes were transfected with 20 Wg
of DNA encoding myc-tagged KIAA0380-RGS/DH/PH, -DH/PH or
-RGS using the calcium phosphate method. Twenty-four h later, cells
were collected from the dishes by trypsination and seeded for a further
24 h on culture slides (Falcon) to allow for studies of the actin cy-
toskeleton. For this, subcon£uent monolayers of J82 cells were rinsed
in Ca2 and Mg2-containing phosphate-bu¡ered saline (PBS), fol-
lowed by incubation with and without LPA for 15 min at 37‡C in
PBS. Thereafter, the cells were washed twice for 5 min with PBS, ¢xed
with 3% paraformaldehyde for 15 min and washed twice for 5 min
with PBS. The cells were permeabilized by incubation for 2 min in a
solution of 0.05% (v/v) Triton X-100, washed twice with PBS and then
incubated for 45 min in 0.5% (w/v) fatty acid-free bovine serum albu-
min in PBS. Then, the cells were treated for 45 min with 5 Wg/ml
mouse anti-myc antibody in 0.5% (w/v) fatty acid-free bovine serum
albumin in PBS, followed by three washes with PBS. Thereafter, the
cells were exposed for another 45 min to an anti-mouse IgG £uores-
cein isothiocyanate conjugate (1:100 dilution, Sigma) in a solution of
tetramethylrhodamine isothiocyanate (TRITC)-phalloidin (25 Wg/ml,
Sigma). After three ¢nal washes with PBS, the stained cells were
mounted with Moviol (Calbiochem) and examined, using a Zeiss Axi-
overt microscope.
3. Results
Protein homology analysis of KIAA0380 revealed that the
predicted aa sequence contains a DH domain (aa 741^928)
followed by a PH domain (aa 965^1079) (Fig. 1). These se-
quences are 61, 64 and 48% identical to the homologous re-
gions of murine Lsc [12], its human homologue p115-Rho-
GEF [13] and Lfc [14], respectively. In addition to the
tandem DH/PH domains, KIAA0380 contains a PDZ domain
at the amino-terminus (aa 47^111) as well as two proline-rich
domains (aa 149^160 and 1089^1099, respectively). Finally,
similar to Lsc and p115-RhoGEF, KIAA0380 contains near
the amino-terminus an RGS homology domain (aa 310^394).
Thus, the sequence analysis predicted that KIAA0380 is a
GEF for Rho-GTPases and it may interact with heterotrimer-
ic G proteins and G protein-coupled receptors.
To determine potential GEF activity of KIAA0380 towards
Rho-GTPases, we expressed and puri¢ed a GST-fused form of
KIAA0380 (KIAA0380-DH/PH) that included the DH and
PH domains as well as some additional £anking sequence.
Since the amino-terminus containing the RGS homology do-
main may act as an intramolecular inhibitor of GEF function,
as described for p115-RhoGEF [4,5], this part was deleted in
the GST fusion protein. Fig. 2A shows that puri¢ed GST-
KIAA0380-DH/PH potently stimulates release of [3H]GDP
bound to puri¢ed GST-RhoA. Half-maximal release of
[3H]GDP from RhoA (0.6 WM) was observed at 0.13 WM
KIAA0380. In contrast, GST-KIAA0380-DH/PH exhibited
no GEF activity towards GST-Rac1 and GST-Cdc42. In the
absence of KIAA0380, there was no release of [3H]GDP from
RhoA over the time course studied (up to 15 min) (Fig. 2B).
Addition of GST-KIAA0380-DH/PH caused a marked accel-
eration of GDP dissociation, reaching half-maximal release at
about 5 min. A similar acceleration of the exchange reaction
by GST-KIAA0380-DH/PH was observed when instead of
[3H]GDP release, binding of [35S]GTPQS to RhoA was exam-
ined (Fig. 2C). Together, these data indicate that KIAA0380
is a potent and speci¢c GEF for RhoA.
Some members of the Dbl family, e.g. Ect-2, bind to Rho-
GTPases but do not induce the GDP/GTP exchange reaction
[15], suggesting that in some cases, the DH domain serves as a
binding motif, perhaps for recruitment and subcellular trans-
location of the GTPases. Therefore, we studied the binding
speci¢cities of KIAA0380 towards RhoA, Rac1 and Cdc42 as
well as the nucleotide dependence of this interaction. For this,
myc-tagged KIAA0380-RGS/DH/PH was expressed in HEK-
293 cells and after cell lysis binding of the expressed protein to
GST-RhoA, -Rac1 and -Cdc42, each, either in the nucleotide-
free, GDP-bound or GTPQS-bound state, was examined. As
shown in Fig. 3, KIAA0380-RGS/PH/DH expressed in HEK-
293 cells (cell lysate) did not bind to GST and also not to
GST-Rac1 and GST-Cdc42 in any of the nucleotide binding
states. In contrast, KIAA0380-RGS/PH/DH bound to GST-
RhoA and this binding occurred best when RhoA was in the
Fig. 1. Schematic representation of KIAA0380 and its domain struc-
ture. In addition to PDZ, RGS, DH and PH domains, KIAA0380
contains two proline-rich regions (P). Below the full-length protein,
the various KIAA0380 variants used in this study are shown, with
the corresponding aa numbers and calculated molecular weights.
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nucleotide-free state. While binding to GDP-RhoA was not
detected, there was substantial binding of KIAA0380-RGS/
PH/DH to GTPQS-liganded RhoA, although clearly less
than to the nucleotide-free GTPase. Thus, KIAA0380 is not
only a RhoA-speci¢c GEF but also binds selectively only to
RhoA but not to Rac1 and Cdc42.
To investigate whether KIAA0380 may act as a Rho-GEF
in vivo, several myc epitope-tagged variants of KIAA0380
were transiently expressed in J82 bladder carcinoma cells.
Speci¢cally, KIAA0380-DH/PH and KIAA0380-RGS/DH/
PH, shown above to exhibit GEF and binding activity to-
wards RhoA, respectively, as well as a variant containing
the RGS homology domain, but lacking the DH and PH
domains (KIAA0380-RGS, see Fig. 1), were studied. Expres-
sion of the KIAA0380 variants was veri¢ed by Western blots
with an anti-myc antibody (data not shown) and by £uores-
cence microscopy using the same antibody. The actin cytos-
keleton was visualized by labelling with TRITC-conjugated
phalloidin. In cells expressing KIAA0380-RGS/DH/PH or
-DH/PH, identi¢ed by positive staining with the anti-myc
antibody, formation of actin stress ¢bers was observed (Fig.
4), similar as in cells expressing V14RhoA, a constitutively
active RhoA mutant (data not shown). These results are in
agreement with the notion that actin stress ¢ber formation is a
RhoA-regulated cellular response [1] and that the KIAA0380
variants expressed in J82 cells speci¢cally bind to and activate
RhoA in vitro (see Figs. 2 and 3).
Since KIAA0380 contains a RGS homology domain, it may
interact with heterotrimeric G proteins, as reported for p115-
RhoGEF [4,5]. Thus, we ¢nally studied the e¡ect of
KIAA0380’s RGS domain on actin stress ¢ber formation in-
duced by LPA, a G protein-coupled receptor agonist. As
shown in Fig. 5, expression of KIAA0380-RGS by itself had
no e¡ect on the actin cytoskeleton in J82 cells, but completely
prevented formation of actin stress ¢bers in response to LPA.
Thus, DH/PH domain-containing variants of KIAA0380 can
apparently activate RhoA in intact cells, whereas KIAA0380-
RGS seems to function as a dominant negative mutant, prob-
ably by interfering with activation of endogenous RhoA.
Fig. 3. RhoA-speci¢c binding of KIAA0380. Binding of myc-tagged
KIAA0380-RGS/DH/PH expressed in HEK-293 cells to GST or
GST fusion proteins of RhoA, Rac1 and Cdc42 was determined as
described in Section 2. The GTPases were either nucleotide-free
(NF) or were binding GDP or GTPQS as indicated. Bound
KIAA0380 was detected with an anti-myc antibody.
Fig. 2. RhoA-speci¢c GEF activity of KIAA0380. A: Concentration
response curve of puri¢ed recombinant GST-KIAA0380-DH/PH on
release of [3H]GDP from recombinant GST-RhoA, Rac1 and Cdc42
(0.6 WM each), measured for 30 min. B: Time course of [3H]GDP
release from GST-RhoA (0.6 WM) in the absence and presence of
GST-KIAA0380-DH/PH (0.46 WM). C: Time course of [35S]GTPQS
binding to GST-RhoA (0.6 WM) in the absence and presence of
GST-KIAA0380-DH/PH (0.46 WM). Inset: Coomassie blue-stained
SDS-PAGE of puri¢ed GST-KIAA0380-DH/PH, with molecular
weight markers on the right. Shown are mean þ S.D. of a represen-
tative experiment out of 2^4, each performed in quadruplicate.
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4. Discussion
Alignments of KIAA0380’s protein sequence with members
of the Dbl family of proteins indicated that KIAA0380 con-
tains a DH domain in tandem with a PH domain as found in
all GEFs of Rho-GTPases and with speci¢c high sequence
homologies to the Rho-speci¢c GEFs, Lsc, p115-RhoGEF
and Lfc. These data suggested that KIAA0380 is a GEF for
Rho-GTPases and possibly speci¢c for Rho. Here, we dem-
onstrate with puri¢ed KIAA0380 and the Rho-GTPases,
RhoA, Rac1 and Cdc42, that KIAA0380 is a speci¢c and
e⁄cient GEF for RhoA, without a¡ecting GDP/GTP ex-
change of Rac1 and Cdc42. Furthermore, it is shown that
KIAA0380 binds speci¢cally to RhoA, but not to Rac1 and
Fig. 4. Formation of actin stress ¢bers by KIAA0380 in J82 cells. TRITC-phalloidin staining of actin (left) and anti-myc antibody immuno-
£uorescence (right) of J82 cells expressing (see arrows) either myc-tagged KIAA0380-RGS/DH/PH (A) or KIAA0380-DH/PH (B). Bar, 20 Wm.
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Cdc42. Finally, expression of KIAA0380 in J82 cells was
found to induce actin stress ¢ber formation, a cellular re-
sponse known to be under speci¢c control by RhoA [1].
Thus, both in vitro and intact cell data indicate that
KIAA0380 is a novel Rho-speci¢c GEF.
During our studies on KIAA0380, Fukuhara et al. [16]
reported that KIAA0380, termed PDZ-RhoGEF by these au-
thors because of KIAA0380’s amino-terminal PDZ domain
with a so far unknown speci¢c function, is widely expressed.
In line with our direct in vitro data, KIAA0380/PDZ-Rho-
GEF overexpressed in NIH-3T3 or COS-7 cells was found to
stimulate a Rho-speci¢c pathway (serum response element
activation), but failed to activate a pathway (activation of c-
Jun N-terminal kinase) regulated by Rac and Cdc42 [16]. In
intact cells, however, it has to be considered that Rho, Rac
and Cdc42 can exhibit extensive overlap as well as crosstalk in
regulating signalling pathways [1] and that cellular responses
induced by individual Rho-GEFs are dependent on and thus
limited by the levels of endogenous Rho-GTPases [17].
In line with the classic GEF-GTPase interaction model,
involving stabilization of a nucleotide-free transition state of
the GTPase by the GEF [3], binding of KIAA0380 to RhoA
was preferential to the nucleotide-free GTPase. While binding
to RhoA-GDP was not detected, there was, however, also
substantial binding of KIAA0380 to GTPQS-liganded RhoA.
In comparison, Lfc, Lsc and Lbc, three other Rho-speci¢c
GEFs, were reported to bind to nucleotide-free RhoA but
not to the GDP- or GTPQS-bound states of RhoA [18]. On
the other hand, mNET1, also a RhoA-speci¢c GEF, bound
GDP- and GTPQS-liganded RhoA equally well ([19], binding
of mNET1 to nucleotide-free RhoA was not reported). Fi-
nally, GEF-H1, a GEF for Rho and Rac, bound to RhoA
and Rac1 irrespective of the nucleotide binding state of these
GTPases [20]. Thus, the nucleotide binding state-speci¢city of
the interaction of Rho-GTPases with their GEFs is apparently
quite distinct, even in the subfamily of Rho-speci¢c GEFs. As
KIAA0380 binds speci¢cally to GTPQS-liganded RhoA, it
may be speculated that KIAA0380 not only acts as a GEF
for RhoA, but at the same time is an e¡ector of activated
RhoA or is a carrier for the active GTPase to potential e¡ec-
tor target sites in cells.
Like Lsc and p115-RhoGEF, KIAA0380 contains an ami-
no-terminal RGS homology domain, suggesting that
KIAA0380 may interact via this domain with heterotrimeric
G proteins, as reported for p115-RhoGEF [4,5], and may thus
interfere with signalling by G protein-coupled receptors. In
fact, Fukuhara et al. [16] reported that KIAA0380/PDZ-Rho-
GEF can form via its RGS domain stable complexes speci¢-
cally with activated GK12 and GK13 and that a DH/PH dele-
tion mutant of KIAA0380/PDZ-RhoGEF reduces Rho-
mediated serum response element activation by GK12 and
GK13. To study whether KIAA0380 via its RGS domain
may interfere with signalling by G protein-coupled receptors,
the e¡ect of KIAA0380 on actin stress ¢ber formation was
studied in J82 cells. This response is induced in J82 cells by
several G protein-coupled receptors, including the LPA recep-
tor, and is a Rho-mediated event [21]. While DH/PH-contain-
ing variants of KIAA0380 induced actin stress ¢ber forma-
tion, KIAA0380-RGS lacking the DH/PH domains by itself
had no e¡ect. However, the stimulatory e¡ect of LPA was
fully prevented by expression of the isolated RGS domain.
As the related Rho-speci¢c GEF, p115-RhoGEF, acts as a
GTPase-activating protein for GK12 and GK13 [4], it may be
speculated that the RGS domain of KIAA0380 shown to
interact with GK12 and GK13 [16] may exhibit a similar activ-
ity towards these G proteins and thereby interrupts signalling
Fig. 5. Block of LPA-induced stress ¢ber formation by the RGS homology domain of KIAA0380. TRITC-phalloidin staining of actin (upper
panel) and anti-myc antibody immuno£uorescence (lower panel) of J82 cells expressing (see arrow) or not myc-tagged KIAA0380-RGS and
stimulated for 15 min with 10 WM LPA. Bar, 20 Wm.
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of the LPA receptor to endogenous Rho. It remains to be
studied whether KIAA0380 which is endogenously expressed
in J82 cells (data not shown) mediates this LPA receptor
signalling and, if yes, by which mechanisms KIAA0380 is
activated, ¢nally leading to activation of RhoA. Interestingly,
the tissue distribution of the two closely related Rho-speci¢c
GEFs, KIAA0380 and p115-RhoGEF, appears to be quite
di¡erent. While expression of KIAA0380 is highest in heart,
brain, placenta, testis and ovary, transcripts for p115-Rho-
GEF were hardly detected in these tissues, whereas strong
expression of p115-RhoGEF was found in spleen, thymus
and peripheral blood leukocytes where less or no expression
of KIAA0380 was found [13,16]. Thus, although functional
di¡erences between these two Rho-speci¢c GEFs may exist,
these two GEFs may function in Rho activation in a tissue-
speci¢c manner.
In summary, we demonstrate here that KIAA0380 speci¢-
cally interacts with RhoA and e⁄ciently stimulates GDP/GTP
exchange of this GTPase, without a¡ecting guanine nucleotide
exchange of Rac1 and Cdc42 or interacting with these
GTPases. In agreement, KIAA0380 induces Rho-speci¢c
pathways in intact cells. By its RGS domain, KIAA0380
may speci¢cally link G protein-coupled receptors to Rho ac-
tivation.
Acknowledgements: We would like to thank S. Olesch and B. Langer
for expert technical assistance. This work was supported by the Deut-
sche Forschungsgemeinschaft and the IFORES program of the Uni-
versita«tsklinikum Essen.
References
[1] Hall, A. (1998) Science 279, 509^514.
[2] Cerione, R.A. and Zheng, Y. (1996) Curr. Opin. Cell Biol. 8,
216^222.
[3] Hart, M.J., Eva, A., Zangrilli, D., Aaronson, S.A., Evans, T.,
Cerione, R.A. and Zheng, Y. (1994) J. Biol. Chem. 269, 62^65.
[4] Kozasa, T., Jiang, X., Hart, M.J., Sternweis, P.M., Singer, W.D.,
Gilman, A.G., Bollag, G. and Sternweis, P.C. (1998) Science 280,
2109^2111.
[5] Hart, M.J., Jiang, X., Kozasa, T., Roscoe, W., Singer, W.D.,
Gilman, A.G., Sternweis, P.C. and Bollag, G. (1998) Science
280, 2112^2114.
[6] Mao, J., Yuan, H. and Wu, D. (1998) Proc. Natl. Acad. Sci.
USA 95, 12973^12976.
[7] Alberts, A.S. and Treisman, R. (1998) EMBO J. 14, 4075^4085.
[8] Self, A.J. and Hall, A. (1995) Methods Enzymol. 256, 3^10.
[9] Zheng, Y., Hart, M.J. and Cerione, R.A. (1995) Methods Enzy-
mol. 256, 77^84.
[10] O’Toole, C., Price, Z.H., Ohnuki, Y. and Unsgaard, B. (1978) Br.
J. Cancer 38, 64^76.
[11] Lu«mmen, G., Virchow, S., Ru«menapp, U., Schmidt, M., Wie-
land, T., Otto, T., Ru«bben, H. and Jakobs, K.H. (1997) Nau-
nyn-Schmiedeberg’s Arch. Pharmacol. 356, 769^776.
[12] Whitehead, I.P., Khosravi-Far, R., Kirk, H., Trigo-Gonzalez, G.,
Der, C.J. and Kay, R. (1996) J. Biol. Chem. 271, 18643^18650.
[13] Hart, M.J., Sharma, S., elMasry, N., Qiu, R.-G., McCabe, P.,
Polakis, P. and Bollag, G. (1996) J. Biol. Chem. 271, 25452^
25458.
[14] Whitehead, I., Kirk, H., Tognon, C., Trigo-Gonzalez, G. and
Kay, R. (1995) J. Biol. Chem. 270, 18388^18395.
[15] Miki, T., Smith, C.L., Long, J.E., Eva, A. and Fleming, T.P.
(1993) Nature 362, 462^465.
[16] Fukuhara, S., Murga, C., Zohar, M., Igishi, T. and Gutkind, J.S.
(1999) J. Biol. Chem. 274, 5868^5879.
[17] Zhou, K., Wang, Y., Gorski, J.L., Nomura, N., Collard, J. and
Bokoch, G.M. (1998) J. Biol. Chem 273, 16782^16786.
[18] Glaven, J.A., Whitehead, I.P., Nomanbhoy, T., Kay, R. and
Cerione, R.A. (1996) J. Biol. Chem. 271, 27374^27381.
[19] Alberts, A.S., Bouquin, N., Johnston, L.H. and Treisman, R.
(1998) J. Biol. Chem. 273, 8616^8622.
[20] Ren, Y., Li, R., Zheng, Y. and Busch, H. (1998) J. Biol. Chem.
273, 34954^34960.
[21] Koch, J., Blomquist, A., Matena, M., Jakobs, K.H. and Ru«me-
napp, U. (1999) Naunyn-Schmiedeberg’s Arch. Pharmacol. 359,
R59.
FEBS 22709 4-10-99
U. Ru«menapp et al./FEBS Letters 459 (1999) 313^318318
